Cancer immunotherapy: breaking the barriers to harvest the crop
- PMID: 15340404
- DOI: 10.1038/nm0904-887
Cancer immunotherapy: breaking the barriers to harvest the crop
Abstract
Successful translation of modern molecular immunology into effective cancer immunotherapy is threatened by regulatory barriers and challenges to the development of novel agents and combinatorial strategies through effective public-private partnerships. For its promise to be fully realized, both the National Cancer Institute and Food and Drug Administration must take active steps to help academic investigators and companies jointly navigate the pathways from laboratory to clinic.
Comment in
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. doi: 10.1038/nm1104-1153a. Nat Med. 2004. PMID: 15516900 No abstract available.
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1154-5; author reply 1155. doi: 10.1038/nm1104-1154. Nat Med. 2004. PMID: 15516901 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
